Effect of fluoxetine on rat liver mitochondria
The DOI matches its Crossref record; 30 of the 32 references it cites were found in a registry or an index.
Abstract
The in vitro and in vivo effects of fluoxetine (and its active metabolite norfluoxetine) on mitochondrial respiration and F0F1-ATPase were studied, respectively, in mitochondria and submitochondrial particles isolated from rat liver. Fluoxetine in vitro inhibited state 3 mitochondrial respiration for alpha-ketoglutarate and succinate oxidations (50% of effect at 0.25 and 0.35 mM drug concentrations, respectively); stimulated state 4 for succinate; and induced a decrease in the respiratory control ratio (RCR) for both oxidizable substrates. The F0F1-ATPase activity was determined at various pH levels in the absence and presence of Triton X-100. The solubilized form was not affected markedly, but an inhibition, apparently non-competitive, was observed for the membrane-bound enzyme, with 50% of the effect at a 0.06 mM drug concentration in pH 7.4. These results suggest that fluoxetine in vitro acts on F0F1-ATPase through direct interaction with the membrane F0 component (similar to oligomycin), or first with mitochondrial membrane and then affecting F0. A very similar behavior concerning the respiratory parameters and F0F1-ATPase properties was observed with norfluoxetine. The in vivo studies with fluoxetine showed stimulation of mitochondrial respiration in state 4 for alpha-ketoglutarate or succinate oxidations in acute or prolonged treatments (1 hr after a single i.p. dose of 20 mg of drug/kg of body weight, and 22 hr after 12 days of treatment with a daily dose of 10 mg/kg o…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Souza et al. (1994) reported that fluoxetine may be potentially hepatotoxic at high doses [7].”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [7]
Citations
Cites
The Pharmacological Basis of Therapeutics
Goodman, L., & Gilhan, A. (1941) · Anesthesiology · doi:10.1097/00000542-194105000-00013 · Cited by 2,146
THE MITOCHONDRIAL ELECTRON TRANSPORT AND OXIDATIVE PHOSPHORYLATION SYSTEM
Hatefi, Y. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.005055 · Cited by 1,680
RESPIRATORY ENZYMES IN OXIDATIVE PHOSPHORYLATION
Chance, B., & Williams, G. R. (1955) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57191-5 · Cited by 1,122
Heinonen, J. K., & Lahti, R. J. (1981) · Analytical Biochemistry · doi:10.1016/0003-2697(81)90082-8 · Cited by 909
The Pharmacological Basis of Therapeutics.
Goodman, L., & Gilman, A. (1941) · Anesthesia & Analgesia · doi:10.1213/00000539-194101000-00064 · Cited by 599
Note on spectrophotometric determination of proteins in dilute solutions
Murphy, J. B., & Kies, M. W. (1960) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(60)91464-5 · Cited by 568
Benfield, P., & Ward, A. (1986) · Drugs · doi:10.2165/00003495-198632040-00002 · Cited by 494
Pedersen, P. L., Greenawalt, J. W., Reynafarje, B., Hullihen, J., Decker, G. L., Soper, J. W., & Bustamente, E. (1978) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)62030-0 · Cited by 445
Anti-schizophrenic drugs—Membrane receptor sites of action
Seeman, P. (1977) · Biochemical Pharmacology · doi:10.1016/0006-2952(77)90340-9 · Cited by 218
Caccia, S., Cappi, M., Fracasso, C., & Garattini, S. (1990) · Psychopharmacology · doi:10.1007/bf02244004 · Cited by 207
Cited by
Mitochondrial Targets of Drug Toxicity
Wallace, K. B., & Starkov, A. A. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.353 · Cited by 464
“Antipsychotic and antidepressant drugs (81, 82), some of the antitumor drugs (83, 84), a number of plasticizers, lipid-lowering drugs and other peroxisome proliferators (85–88), antimycotics (89, 90), drugs used to treat trypanosomiasis and leishmaniasis (91), numerous antihelmintics (92–94), antispermatogenic drugs (…”
BackgroundMitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression
Allen, J., Romay-Tallon, R., Brymer, K. J., Caruncho, H. J., & Kalynchuk, L. E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00386 · Cited by 347
“In the rat liver, fluoxetine administered in vitro inhibited state 3 of mitochondrial respiration for α-ketoglutarate and succinate oxidation, stimulated state 4 for succinate, and decreased the respiratory control ratio for both oxidizable substrates (Souza et al., 1994).”
BackgroundGardner, A., & Boles, R. G. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.030 · Cited by 333
“Fluoxetine has been found to exert multiple effects on the energy metabolism of rat liver mitochondria, being potentially toxic in high doses (Souza et al., 1994), and to affect electron transport and ATPase activity inhibiting ATP production in isolated rat brain mitochondria (Curti et al.”
BackgroundAndrews, P. W., Bharwani, A., Lee, K. R., Fox, M., & Thomson, J. A. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.01.018 · Cited by 281
“, 2013), inhibit oxidative phosphorylation in liver and brain mitochondria (Curti et al., 1999; Souza et al., 1994), and inhibit the consumption of blood-borne glucose throughout the brain (Freo et al.”
Behr, G. A., Moreira, J. C. F., & Frey, B. N. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/609421 · Cited by 205
“(1994) reported that fluoxetine may be potentially hepatotoxic at high doses [7].”
Background
Metadata
- Authors
- Souza, M. E. J., Polizello, A. C. M., Uyemura, S. A., Castro-Silva, O., & Curti, C.
- Affiliations
- Universidade de São Paulo (BR)
- Corresponding author
- Curti, Carlos
- Venue
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Published
- 1994-08
- Volume
- 48
- Issue
- 3
- Pages
- 535-541
- ISSN
- 0006-2952 (ISSN-L)
- OpenAlex
- W2063989420
- Semantic Scholar
- 98352b330d58ae38f4ca4f25a8b84dfceda15368
- Cited by
- 95
- References
- 32
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 8 · 2020: 2 · 2019: 1 · 2018: 4 · 2017: 10 · 2016: 7 · 2015: 4 · 2014: 7 · 2013: 2 · 2012: 5
- FWCI
- 0.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Biochemical Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › ATP Synthase and ATPases Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- fluoxetine, norfluoxetine, liver mitochondria, mitochondrial respiration, ATP synthase, respiratory control ratio, mitochondrial uncoupling, drug toxicity, energy metabolism, alpha-ketoglutarate oxidation, succinate oxidation
- MeSH terms
- Animals, Dose-Response Relationship, Drug, Energy Metabolism, Fluoxetine, Proton-Translocating ATPases, Ketoglutaric Acids, Male, Mitochondria, Liver, Succinates, Rats, Wistar, Succinic Acid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of fluoxetine on rat liver mitochondria. https://app.cochat.ai/papers/10.1016/0006-2952(94)90283-6
- The paper
- Souza, M. E. J., Polizello, A. C. M., Uyemura, S. A., Castro-Silva, O., & Curti, C. (1994). Effect of fluoxetine on rat liver mitochondria. Biochemical Pharmacology. https://doi.org/10.1016/0006-2952(94)90283-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.